 |
|
| February 4, 2010 |
Net Conference for the Third Quarter of FY2009 Consolidated Result |
| February 4, 2010 |
Consolidated Financial Report for the Third Quarter of Fiscal Year Ending March 31, 2010 |
| November 5, 2009 |
Net Conference for the First Half of FY2009 Consolidated Result |
| November 5, 2009 |
Consolidated Financial Report for the First Half of Fiscal Year Ending March 31, 2010 |
| October 22, 2009 |
Ube Industries Announces Revised Earnings Forecast |
| August 10, 2009 |
Net Conference for the First Quarter of FY2009 Consolidated Result |
| August 3, 2009 |
Consolidated Financial Report for the First Quarter of Fiscal Year Ending March 31, 2010 |
| July 13, 2009 |
Ube Industries Announces Decision on Amount to be Paid for Stock Options (Stock Acquisition Rights) in Stock-Linked Compensation Plan |
| July 13, 2009 |
FDA Approves EFFIENTTM(prasugrel) Antiplatelet Agent |
| June 26, 2009 |
Ube Industries Announces Issue of Stock Acquisition Rights as
Stock Options for Stock-Linked Compensation Plan |
| June 26, 2009 |
Resolutions of the 103rd Ordinary General Meeting of Shareholders |
| June 4, 2009 |
Notice of the 103rd Ordinary General Meeting
of Shareholders |
| May 26, 2009 |
Information Meeting: FY2008 Consolidated Result in New Mid-Term Management Plan "Stage up 2009" : Archives |
| May 18, 2009 |
Information Meeting: FY2008 Consolidated Result in New Mid-Term Management Plan "Stage up 2009" |
| May 11, 2009 |
Net Conference for the FY2008 Consolidated Result |
| May 11, 2009 |
Consolidated Financial Report for the Fiscal Year Ended March 31, 2009 |
| May 11, 2009 |
Ube Industries to Propose Partial Amendment to Articles of Incorporation |
| April 28, 2009 |
Ube Industries Announces the Establishment of a Subsidiary Company Following Corporate Separation of Its Aluminum Wheel Business |
| April 28, 2009 |
Ube Industries Announces Executive Personnel Changes |
| April 28, 2009 |
Ube Industries Announces Resolution Concerning Basic Policy on Creation of Internal Control System |
| May 31, 2009 |
Ube Industries Announces Spinning Off Aluminum Wheel Business |
| February 23, 2009 |
European Commission Approves EFIENTTM (prasugrel)
for Patients with Acute Coronary Syndrome Undergoing PCI |
| February 12, 2009 |
Net Conference for the Third Quarter of FY2008 Consolidated Result |
| February 6, 2009 |
Consolidated Financial Report for the Third Quarter of Fiscal Year Ending March 31, 2009 |
| February 6, 2009 |
Ube Industries Announces Revised Earnings and Dividend Forecast |
| February 6, 2009 |
Ube Industries Announces Dissolution of North American Wheel Manufacturing Operations |
| February 4, 2009 |
FDA Advisory Committee Issues Approval Recommendation for Prasugrel, Antiplatelet Agent |
